fregime

What actually happened to the stocks you care about: every claim cited, corroboration counted, never opinions.

Development · 26 Aug 2026

GLENMARK, full dossier

Glenmark Pharmaceuticals Ltd stock price rose 1.8% on August 26, 2026, reaching Rs 2443.1 on the NSE.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Glenmark Pharmaceuticals Ltd stock price rose 1.8% on August 26, 2026, reaching Rs 2443.1 on the NSE.

A single act of reporting so far, corroborating sources join this record as they publish.

Glenmark Pharmaceuticals

₹2,438.30

+1.60%

Close (EOD), as of 26 Aug 2026 · source

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.